Abstract
Hemorrhagic shock is a critical condition frequently complicated by acute kidney injury (AKI). This study investigates the "gut-lymph" hypothesis, exploring how toxic factors in mesenteric lymph disrupt the Renin-Angiotensin System (RAS) equilibrium in the kidneys. By employing surgical, pharmacological, and genetic mouse models, researchers demonstrate that mesenteric lymph return triggers an imbalance between the harmful ACE-AngII-AT1R axis and the protective ACE2-Ang(1-7)-MasR axis. Restoring this balance, particularly through mesenteric lymph duct ligation (MLDL), significantly mitigates renal damage.
Introduction
Acute kidney injury following severe blood loss (hemorrhagic shock) remains a major clinical challenge in intensive care. While the Renin-Angiotensin System (RAS) is known to regulate blood pressure and fluid balance during shock, its specific role in localized organ damage is complex. The "gut-lymph" hypothesis posits that intestinal ischemia during shock leads to the release of toxic mediators into the mesenteric lymph, which then travels to distant organs. This study sought to determine if these lymph-borne factors cause AKI by disrupting the local RAS balance in the kidney.
Methods
The researchers utilized a mouse model of acute hemorrhage, maintaining blood pressure at 40 mmHg for 60 minutes before fluid resuscitation. To isolate the mechanisms of injury, several experimental groups were established:
- Surgical Intervention: Mesenteric lymph duct ligation (MLDL) was used to block the return of "toxic" lymph to the systemic circulation.
- Pharmacological Modulation: Mice were treated with Enalapril (ACE inhibitor), Losartan (AT1R inhibitor), or Angiotensin (1-7) to target specific components of the RAS.
- Genetic and Pathway Validation: $ACE2$ knockout mice ($ACE2^{-/-}$), Angiotensin II administration, and Mas receptor inhibitors (A-779) were used to test the necessity of the protective RAS axis.
- Analysis: Renal health was assessed via H&E staining for histomorphology, immunohistochemistry for protein expression (ACE, ACE2, AT1R, MasR), and ELISA for peptide levels (Ang II and Ang (1-7)).
Results
Hemorrhagic shock significantly altered the renal RAS profile, nearly doubling the levels of the pro-inflammatory peptide Angiotensin II and halving the levels of the protective peptide Angiotensin (1-7). This was accompanied by increased expression of ACE and AT1R, and decreased expression of ACE2 and MasR in kidney tissue.
Surgical ligation of the lymph duct (MLDL) effectively reversed these changes, preserving kidney tissue structure and normalizing protein expression levels (as measured by grayscale values). Similarly, treatment with Enalapril, Losartan, or Ang (1-7) mimicked the protective effects of MLDL. Crucially, the benefits of MLDL were abolished in $ACE2^{-/-}$ mice and in mice treated with Ang II or the MasR inhibitor A-779, indicating that the protective effect of blocking lymph return is dependent on the activation of the ACE2-Ang(1-7)-MasR pathway.
Discussion and Conclusion
This study provides strong evidence that mesenteric lymph return is a primary driver of RAS imbalance in the kidneys following hemorrhagic shock. The findings highlight a "tug-of-war" between two RAS axes: the harmful ACE-AngII-AT1R axis and the protective ACE2-Ang(1-7)-MasR axis.
The results suggest that factors within the mesenteric lymph act as a switch that overactivates the harmful axis while suppressing the protective one. While MLDL is an effective experimental intervention, its clinical application is limited by its invasiveness. However, the success of pharmacological agents like Enalapril and Losartan in this model suggests that targeting the RAS equilibrium may offer a viable therapeutic strategy for preventing AKI in trauma patients. Future research is needed to identify the specific toxic components within the mesenteric lymph that trigger this systemic response.
Summary updated